The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and ...

Drugs like Ozempic and Wegovy may provide a surprising, life-saving benefit for the youngest patients taking these diabetes and weight loss medications.

Researchers said the drugs don’t appear to raise the risk of suicidal thoughts or actions for young people but also urged ...

That’s according to a new Employer Health Benefits Survey from KFF (formerly the Kaiser Family Foundation). But while a ...

The market for injectable weight loss medications has experienced rapid growth. Goldman Sachs Research predicts the global ...

Still, more than a quarter of employers are considering adding coverage for GLP-1 drugs for weight loss in 2025 or 2026, according to a national survey conducted this year by Mercer, a human resources ...

A highly effective class of weight loss drug has taken the world by storm, as medications like Ozempic, Wegovy, and Zepbound become household names. These drugs, originally meant to treat diabetes, ...

Ilant estimates that behavioral therapy can help many people lose up to 5% of their weight, anti-obesity medications can help ...

Doctors are already using weight loss drugs to treat binge eating disorder. But some experts warn that it’s a Band-Aid, not a ...

Kailera Therapeutics launched on Tuesday as the latest startup seeking a slice of the booming market for anti-obesity therapies with a rare $400 million in early-stage funding.

Investors have been closely watching Roche's efforts to crack into the booming obesity market, which has lifted the fortunes of Novo Nordisk and Eli Lilly thanks to the huge popularity of drugs ...

The drug's efficacy, combined with an acceptable safety and tolerability profile, positions it as a potential game-changer in the obesity treatment landscape. 2. INV-202 (CB1 inverse agonist ...